Skip to main content
Erschienen in: Acta Neurochirurgica 8/2014

01.08.2014 | Clinical Article - Functional

Longitudinal changes in seizure outcomes after resection of cerebral cavernous malformations in patients presenting with seizures: a long-term follow-up of 46 patients

verfasst von: Jiha Kim, Chi Heon Kim, Chun Kee Chung

Erschienen in: Acta Neurochirurgica | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Seizure is the most common presentation in patients with cerebral cavernous malformations (CCMs). Although many articles have documented seizure outcomes after resection of CCM, few have conducted long-term follow-ups; thus, the fluctuating seizure outcomes have been neglected. The purpose of this study is to describe long-term postoperative seizure outcomes in patients with CCM and to compare seizure outcomes between patients with sporadic seizures and those with chronic seizures.

Methods

Forty-six patients with CCM presenting with seizures underwent surgery. The male-to-female ratio was 1:1, and the average age at initial seizure onset was 27.6 years. The mean preoperative seizure duration was 42.7 months. Patients were divided into two groups: a chronic group (N = 20) and a sporadic group (N = 26) according to seizure frequency and duration. The mean postoperative follow-up duration was 96.3 months, and the postoperative seizure outcomes were checked annually based upon Engel’s classification.

Results

After the first year of follow-up, 80.8 % of the sporadic group and 75.0 % of the chronic group were evaluated as Engel class I. These rates increased to 100.0 % and 90.0 %, respectively, at the eighth year of follow-up. Overall, 29 (63.0 %) of the 46 patients experienced changes in seizure outcomes over the follow-up period. Despite their delayed improvements, the chronic group showed less favorable outcomes throughout follow-up (p = 0.025).

Conclusions

Long-term follow-up is indispensable for accurately assessing postoperative seizure outcomes because these outcomes change continuously. We recommend earlier surgery to achieve seizure-free status in patients with CCM. However, even in the chronic group, surgery is recommended, considering the overall delayed improvement.
Literatur
1.
Zurück zum Zitat Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermann F, Siegel AM (2007) Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 48:559–563PubMedCrossRef Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermann F, Siegel AM (2007) Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 48:559–563PubMedCrossRef
2.
Zurück zum Zitat Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, Siegel AM (2006) Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47:563–566PubMedCrossRef Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, Siegel AM (2006) Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47:563–566PubMedCrossRef
3.
Zurück zum Zitat Bernotas G, Rastenyte D, Deltuva V, Matukevicius A, Jaskeviciene V, Tamasauskas A (2009) Cavernous angiomas: an uncontrolled clinical study of 87 surgically treated patients. Medicina (Kaunas) 45:21–28 Bernotas G, Rastenyte D, Deltuva V, Matukevicius A, Jaskeviciene V, Tamasauskas A (2009) Cavernous angiomas: an uncontrolled clinical study of 87 surgically treated patients. Medicina (Kaunas) 45:21–28
4.
Zurück zum Zitat Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E (1997) Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 99:179–183PubMedCrossRef Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E (1997) Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 99:179–183PubMedCrossRef
5.
Zurück zum Zitat Cohen DS, Zubay GP, Goodman RR (1995) Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83:237–242PubMedCrossRef Cohen DS, Zubay GP, Goodman RR (1995) Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83:237–242PubMedCrossRef
6.
Zurück zum Zitat Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS, Chalouhi N, Randazzo C, Rosenwasser R, Jabbour P (2011) Management of incidental cavernous malformations: a review. Neurosurg Focus 31:1–5 Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS, Chalouhi N, Randazzo C, Rosenwasser R, Jabbour P (2011) Management of incidental cavernous malformations: a review. Neurosurg Focus 31:1–5
7.
Zurück zum Zitat Englot DJ, Han SJ, Lawton MT, Chang EF (2011) Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 115:1169–1174PubMedCrossRef Englot DJ, Han SJ, Lawton MT, Chang EF (2011) Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 115:1169–1174PubMedCrossRef
8.
Zurück zum Zitat Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G (2006) Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci 26:390–394PubMedCrossRef Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G (2006) Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci 26:390–394PubMedCrossRef
9.
Zurück zum Zitat Hammen T, Romstock J, Dorfler A, Kerling F, Buchfelder M, Stefan H (2007) Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 16:248–253PubMedCrossRef Hammen T, Romstock J, Dorfler A, Kerling F, Buchfelder M, Stefan H (2007) Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 16:248–253PubMedCrossRef
10.
Zurück zum Zitat Kelemen A, Barsi P, Eross L, Vajda J, Czirjak S, Borbely C, Rasonyi G, Halasz P (2006) Long-term outcome after temporal lobe surgery—prediction of late worsening of seizure control. Seizure 15:49–55PubMedCrossRef Kelemen A, Barsi P, Eross L, Vajda J, Czirjak S, Borbely C, Rasonyi G, Halasz P (2006) Long-term outcome after temporal lobe surgery—prediction of late worsening of seizure control. Seizure 15:49–55PubMedCrossRef
11.
Zurück zum Zitat Kim W, Stramotas S, Choy W, Dye J, Nagasawa D, Yang I (2011) Prognostic factors for post-operative seizure outcomes after cavernous malformation treatment. J Clin Neurosci 18:877–880PubMedCrossRef Kim W, Stramotas S, Choy W, Dye J, Nagasawa D, Yang I (2011) Prognostic factors for post-operative seizure outcomes after cavernous malformation treatment. J Clin Neurosci 18:877–880PubMedCrossRef
12.
Zurück zum Zitat Kivelev J, Niemela M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153:261–270CrossRef Kivelev J, Niemela M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153:261–270CrossRef
13.
Zurück zum Zitat Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077PubMedCrossRef Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077PubMedCrossRef
14.
Zurück zum Zitat Moran NF, Fish DR, Kitchen N, Shorvon S, Kendall BE, Stevens JM (1999) Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 66:561–568PubMedCentralPubMedCrossRef Moran NF, Fish DR, Kitchen N, Shorvon S, Kendall BE, Stevens JM (1999) Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 66:561–568PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E (2008) Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 63:888–896, discussion 897PubMedCrossRef Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E (2008) Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 63:888–896, discussion 897PubMedCrossRef
16.
Zurück zum Zitat Stefan H, Hammen T (2004) Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 110:393–397PubMedCrossRef Stefan H, Hammen T (2004) Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 110:393–397PubMedCrossRef
17.
Zurück zum Zitat Upchurch K, Stern JM, Salamon N, Dewar S, Engel J Jr, Vinters HV, Fried I (2010) Epileptogenic temporal cavernous malformations: operative strategies and postoperative seizure outcomes. Seizure 19:120–128PubMedCrossRef Upchurch K, Stern JM, Salamon N, Dewar S, Engel J Jr, Vinters HV, Fried I (2010) Epileptogenic temporal cavernous malformations: operative strategies and postoperative seizure outcomes. Seizure 19:120–128PubMedCrossRef
18.
Zurück zum Zitat Van Gompel JJ, Marsh WR, Meyer FB, Worrell GA (2010) Patient-assessed satisfaction and outcome after microsurgical resection of cavernomas causing epilepsy. Neurosurg Focus 29:E16PubMedCentralPubMedCrossRef Van Gompel JJ, Marsh WR, Meyer FB, Worrell GA (2010) Patient-assessed satisfaction and outcome after microsurgical resection of cavernomas causing epilepsy. Neurosurg Focus 29:E16PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC (2009) Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients. Seizure 18:14–20PubMedCrossRef Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC (2009) Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients. Seizure 18:14–20PubMedCrossRef
20.
Zurück zum Zitat Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ (1996) Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir (Wien) 138:672–677CrossRef Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ (1996) Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir (Wien) 138:672–677CrossRef
Metadaten
Titel
Longitudinal changes in seizure outcomes after resection of cerebral cavernous malformations in patients presenting with seizures: a long-term follow-up of 46 patients
verfasst von
Jiha Kim
Chi Heon Kim
Chun Kee Chung
Publikationsdatum
01.08.2014
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 8/2014
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-014-2121-x

Weitere Artikel der Ausgabe 8/2014

Acta Neurochirurgica 8/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.